Please use this identifier to cite or link to this item:
Scopus Web of ScienceĀ® Altmetric
Type: Journal article
Title: The utility of the proliferative index in pretreatment biopsy specimens of esophageal squamous cell carcinoma
Author: Zhang, X.
Coventry, B.
Jamieson, G.
Gill, P.
Citation: Diseases of the Esophagus, 1998; 11(4):215-220
Publisher: Oxford University Press (OUP)
Issue Date: 1998
ISSN: 1120-8694
Abstract: The proliferative index detected immunohistochemically by monoclonal antibody MIB-1 from pre-treatment biopsy tissues of 33 patients with esophageal squamous cell carcinoma who underwent preoperative concurrent chemoradiotherapy was evaluated in relation to clinicopathologic features and chemoradiotherapeutic responses. The response to chemoradiotherapy was assessed both endoscopically and pathologically and classified as complete or partial response. Higher MIB-1 LI was significantly associated with lymph node metastases, suggesting that detection of MIB-1 LI from biopsy tissues may contribute to pre-treatment staging of tumors and prediction of persistence of lymph node involvement after chemoradiotherapy, which would permit the optimization of systemic treatment for individual patients. Statistically, significant correlation existed between higher MIB 1-LI and poor overall survival, implicating the prognostic significance of the MIB-1 LI in patients undergoing multimodality treatment. No significant relationship was found between the MIB-1 LI and either endoscopic or pathologic responses, although a trend for tumors with lower MIB-1 LI to have better responses was observed.
Keywords: Humans
Carcinoma, Squamous Cell
Esophageal Neoplasms
Ki-67 Antigen
Antibodies, Monoclonal
Combined Modality Therapy
Cell Division
Middle Aged
DOI: 10.1093/dote/11.4.215
Appears in Collections:Aurora harvest 2
Surgery publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.